SILO PHARMA, INC. Operating Expenses
SILO PHARMA, INC. (SILO) reported Operating Expenses of $928.95 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- SILO PHARMA, INC. operating expenses for the quarter ending 2026-06-30 was $928.95K, a 26.57% decline year-over-year.
- SILO PHARMA, INC. operating expenses for the quarter ending 2026-03-31 was $1.59M, a 43.33% increase year-over-year.
- SILO PHARMA, INC. operating expenses for the quarter ending 2025-12-31 was $783.86K, a 57.16% decline year-over-year.
- SILO PHARMA, INC. operating expenses for the quarter ending 2025-09-30 was $1.15M, a 11.90% increase year-over-year.
- SILO PHARMA, INC. operating expenses for fiscal 2023 was $3.92M, a 6.17% increase from fiscal 2022.
- SILO PHARMA, INC. operating expenses for fiscal 2022 was $3.69M, a 31.43% increase from fiscal 2021.
- SILO PHARMA, INC. operating expenses for fiscal 2021 was $2.81M, a 27.65% increase from fiscal 2020.
- SILO PHARMA, INC. operating expenses for fiscal 2020 was $2.20M, a 133.34% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $928.95K 10-Q · filed 2026-08-13 | $2.52M 10-Q · filed 2026-08-13 | $3.30M derived: sum of 3 quarters · filed 2026-08-13 | $4.45M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.59M 10-Q · filed 2026-05-14 | $2.38M derived: sum of 2 quarters · filed 2026-05-14 | $3.52M derived: sum of 3 quarters · filed 2026-05-14 | $4.79M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $783.86K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $1.93M derived: sum of 2 quarters · filed 2026-04-14 | $3.20M derived: sum of 3 quarters · filed 2026-08-13 | $4.31M POS AM · filed 2026-04-14 | ||||
| 2025-09-30 | $1.15M 10-Q · filed 2025-11-13 | $2.41M derived: sum of 2 quarters · filed 2026-08-13 | $3.52M 10-Q · filed 2025-11-13 | $5.35M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.27M 10-Q · filed 2026-08-13 | $2.38M 10-Q · filed 2026-08-13 | $4.21M derived: sum of 3 quarters · filed 2026-08-13 | $5.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.11M 10-Q · filed 2026-05-14 | $2.94M derived: sum of 2 quarters · filed 2026-05-14 | $3.97M derived: sum of 3 quarters · filed 2026-05-14 | $4.99M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.83M derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $2.86M derived: sum of 2 quarters · filed 2026-04-14 | $3.88M derived: sum of 3 quarters · filed 2026-04-14 | $4.77M POS AM · filed 2026-04-14 | ||||
| 2024-09-30 | $1.03M 10-Q · filed 2025-11-13 | $2.05M derived: sum of 2 quarters · filed 2025-11-13 | $2.94M 10-Q · filed 2025-11-13 | $4.12M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.02M 10-Q · filed 2025-08-13 | $1.92M 10-Q · filed 2025-08-13 | $3.10M derived: sum of 3 quarters · filed 2025-08-13 | $3.89M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $896.08K 10-Q · filed 2025-05-09 | $2.08M derived: sum of 2 quarters · filed 2025-05-09 | $2.87M derived: sum of 3 quarters · filed 2025-05-09 | $4.00M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.97M derived: sum of 2 quarters · filed 2025-03-28 | $3.10M derived: sum of 3 quarters · filed 2025-03-28 | $3.92M 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | $789.96K 10-Q · filed 2024-11-12 | $1.92M derived: sum of 2 quarters · filed 2024-11-12 | $2.74M 10-Q · filed 2024-11-12 | $4.42M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.13M 10-Q · filed 2024-08-13 | $1.95M 10-Q · filed 2024-08-13 | $3.63M derived: sum of 3 quarters · filed 2024-08-13 | $4.59M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $820.05K 10-Q · filed 2024-05-13 | $2.49M derived: sum of 2 quarters · filed 2024-05-13 | $3.46M derived: sum of 3 quarters · filed 2024-05-13 | $3.97M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.64M derived: sum of 2 quarters · filed 2024-03-25 | $3.15M derived: sum of 3 quarters · filed 2024-03-25 | $3.69M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $965.72K 10-Q · filed 2023-11-13 | $1.48M derived: sum of 2 quarters · filed 2023-11-13 | $2.02M 10-Q · filed 2023-11-13 | $2.98M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $510.85K 10-Q · filed 2023-08-11 | $1.05M 10-Q · filed 2023-08-11 | $2.01M derived: sum of 3 quarters · filed 2023-08-11 | $2.49M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $543.83K 10-Q · filed 2023-05-12 | $1.50M derived: sum of 2 quarters · filed 2023-05-12 | $1.98M derived: sum of 3 quarters · filed 2023-05-12 | $2.44M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $958.98K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.44M derived: sum of 2 quarters · filed 2023-03-24 | $1.89M derived: sum of 3 quarters · filed 2023-03-24 | $2.81M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $480.51K 10-Q · filed 2022-11-10 | $933.92K derived: sum of 2 quarters · filed 2022-11-10 | $1.85M 10-Q · filed 2022-11-10 | $2.44M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $453.42K 10-Q · filed 2022-08-01 | $539.62K 10-Q · filed 2021-08-13 | $1.37M 10-Q · filed 2022-08-01 | $1.52M 10-Q · filed 2021-08-13 | $1.96M derived: sum of 3 quarters · filed 2022-08-01 | $2.52M derived: sum of 4 quarters · filed 2022-08-01 | ||
| 2021-03-31 | $917.70K 10-Q · filed 2022-05-13 | $983.59K 10-Q · filed 2021-05-17 | $1.51M derived: sum of 2 quarters · filed 2022-05-13 | $2.07M derived: sum of 3 quarters · filed 2022-05-13 | $3.07M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $591.58K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $1.15M derived: sum of 2 quarters · filed 2022-03-28 | $2.15M derived: sum of 3 quarters · filed 2022-03-28 | $2.20M 10-K · filed 2022-03-28 | $2.44M 10-K · filed 2021-03-29 | |||
| 2020-09-30 | $558.89K 10-Q · filed 2021-11-10 | $623.06K 10-Q · filed 2020-11-05 | $1.56M derived: sum of 2 quarters · filed 2021-11-10 | $1.61M 10-Q · filed 2021-11-10 | $1.78M 10-Q · filed 2020-11-05 | $2.05M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $997.58K 10-Q · filed 2021-08-13 | $1.16M 10-Q · filed 2021-08-13 | $1.49M derived: sum of 3 quarters · filed 2021-08-13 | $1.74M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $159.57K 10-Q · filed 2021-05-17 | $496.02K derived: sum of 2 quarters · filed 2021-05-17 | $738.71K derived: sum of 3 quarters · filed 2021-05-17 | $928.59K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $336.45K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $579.15K derived: sum of 2 quarters · filed 2021-05-17 | $769.02K derived: sum of 3 quarters · filed 2021-05-17 | $943.59K 10-K/A · filed 2021-05-17 | ||||
| 2019-09-30 | $242.69K 10-Q · filed 2020-11-05 | $432.57K derived: sum of 2 quarters · filed 2020-11-05 | $607.13K 10-Q · filed 2020-11-05 | $909.23K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $189.87K 10-Q · filed 2020-08-14 | $364.44K 10-Q · filed 2020-08-14 | $666.54K derived: sum of 3 quarters · filed 2020-08-14 | $747.72K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $174.56K 10-Q · filed 2020-05-12 | $476.66K derived: sum of 2 quarters · filed 2020-05-12 | $557.84K derived: sum of 3 quarters · filed 2020-05-12 | $633.95K derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $302.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $383.28K derived: sum of 2 quarters · filed 2020-03-20 | $459.39K derived: sum of 3 quarters · filed 2020-03-20 | $594.24K 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | $81.18K 10-Q · filed 2019-11-13 | $157.29K derived: sum of 2 quarters · filed 2019-11-13 | $292.14K 10-Q · filed 2019-11-13 | $461.48K derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $76.11K 10-Q · filed 2019-08-13 | $210.96K 10-Q · filed 2019-08-13 | $380.30K derived: sum of 3 quarters · filed 2019-08-13 | $478.46K derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $134.85K 10-Q · filed 2019-05-14 | $304.19K derived: sum of 2 quarters · filed 2019-05-14 | $402.35K derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $169.34K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-04 | $267.50K derived: sum of 2 quarters · filed 2019-04-04 | $490.87K 10-K · filed 2019-04-04 | |||||
| 2017-09-30 | $98.16K 10-Q · filed 2018-11-14 | $321.53K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |